[Intervention treatment with percutaneous trans-arterial implantation of port-catheter system for advanced cancer patients].
OBJECTIVE
To examine the feasibility, clinical efficacy and complications of percutaneous trans-arterial implantation of port-catheter system (PCS) for intervention treatment of advanced malignant tumors.


METHODS
Fifty-three cases with advanced malignant tumors were treated by infusion of chemotherapeutic drugs and/or chemo-embolization through PCS. Patients received one course of treatment every 4-6 weeks.


RESULTS
In this series of treated patients, the survival period was 5-18 months with a mean survival time of 13.5 months. The overall response rate (CR + PR) was 62.3%. Detachment of the catheter tip occurred in 2 cases. Disruption of wound after removal of stitches occurred in one case and skin necrosis at the port occurred in another.


CONCLUSIONS
Long-term intervention treatment with PCS is simple and safe. It is a treatment of choice for patients with advanced malignancy.
Huang
J
J
Cancer Center, Sun Yat-sen University of Medical Sciences, Guangzhou 510060.
Wu
P
P
Zhang
F
F
D000328:Adult; D000368:Aged; D016461:Chemoembolization, Therapeutic / Q000379:methods*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000401:mortality; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000401:mortality